When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ASRT - Collegium Pharma buys Nucynta U.S. rights from Assertio in $375M deal
Assertio Therapeutics Inc.
Collegium Pharmaceutical (NASDAQ:COLL) +8.3% after-hours on news it agrees to acquire the U.S. rights to the Nucynta franchise from Assertio Therapeutics (NASDAQ:ASRT) for $375M; ASRT +56.7%.
More news on: Collegium Pharmaceutical, Inc., Assertio Therapeutics, Inc., Healthcare stocks news, Stocks on the move,